Thyroid Fine-Needle Aspiration Cytology Practice in Korea
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
We reviewed the current status of thyroid fine-needle aspiration cytology (FNAC) in Korea. Thyroid aspiration biopsy was first introduced in Korea in 1977. Currently, radiologists aspirate the thyroid nodule under the guidance of ultrasonography, and cytologic interpretation is only legally approved when a cytopathologist makes the diagnosis. In 2008, eight thyroid-related societies came together to form the Korean Thyroid Association. The Korean Society for Cytopathology and the endocrine pathology study group of the Korean Society for Pathologists have been updating the cytologic diagnostic guidelines. The Bethesda System for Reporting Thyroid Cytopathology was first introduced in 2009, and has been used by up to 94% of institutions by 2016. The average diagnosis rates are as follows for each category: I (12.4%), II (57.9%), III (10.4%), IV (2.9%), V (3.7%), and VI (12.7%). The malignancy rates in surgical cases are as follows for each category: I (28.7%), II (27.8%), III (50.6%), IV (52.3%), V (90.7%), and VI (100.0%). Liquid-based cytology has been used since 2010, and it was utilized by 68% of institutions in 2016. The categorization of thyroid lesions into “atypia of undetermined significance” or “follicular lesion of undetermined significance” is necessary to draw consensus in our society. Immunocytochemistry for galectin-3 and BRAF is used. Additionally, a molecular test for BRAF in thyroid FNACs is actively used. Core biopsies were performed in only 44% of institutions. Even the institutions that perform core biopsies only perform them for less than 3% of all FNACs. However, only 5% of institutions performed core biopsies up to three times more than FNAC.
Abstract
We reviewed the current status of thyroid fine-needle aspiration cytology (FNAC) in Korea. Thyroid aspiration biopsy was first introduced in Korea in 1977. Currently, radiologists aspirate the thyroid nodule under the guidance of ultrasonography, and cytologic interpretation is only legally approved when a cytopathologist makes the diagnosis. In 2008, eight thyroid-related societies came together to form the Korean Thyroid Association. The Korean Society for Cytopathology and the endocrine pathology study group of the Korean Society for Pathologists have been updating the cytologic diagnostic guidelines. The Bethesda System for Reporting Thyroid Cytopathology was first introduced in 2009, and has been used by up to 94% of institutions by 2016. The average diagnosis rates are as follows for each category: I (12.4%), II (57.9%), III (10.4%), IV (2.9%), V (3.7%), and VI (12.7%). The malignancy rates in surgical cases are as follows for each category: I (28.7%), II (27.8%), III (50.6%), IV (52.3%), V (90.7%), and VI (100.0%). Liquid-based cytology has been used since 2010, and it was utilized by 68% of institutions in 2016. The categorization of thyroid lesions into “atypia of undetermined significance” or “follicular lesion of undetermined significance” is necessary to draw consensus in our society. Immunocytochemistry for galectin-3 and BRAF is used. Additionally, a molecular test for BRAF in thyroid FNACs is actively used. Core biopsies were performed in only 44% of institutions. Even the institutions that perform core biopsies only perform them for less than 3% of all FNACs. However, only 5% of institutions performed core biopsies up to three times more than FNAC.
참고문헌 (31)
- 김미미, "A Nationwide Multicenter Survey by the Korean Society of Endocrine Pathologists", Journal of Pathology and Translational Medicine, 51(4), pp.410~417 (2017), 대한병리학회
- Lipton RF, "Aspiration biopsy and the thyroid in evaluation of thyroid dysfunction", Am J Med Sci, 208, pp.736~742 (1944)
- Crile G Jr, "Aspiration biopsy of thyroid nodules", Surg Gynecol Obstet, 136, pp.241~245 (1973)
- Lee MH, "Thyroid biopsy", Korean J Med, 20, pp.731~736 (1977)
- Park HS, "Cytohistopathologic comparative study of aspiration biopsy cytology from various sites", Korean J Cytopathol, 2, pp.8~19 (1991)
- Lee K, "The history of the Korean Society for Cytopathology", pp.15~19 (2006), The Korean Society for Cytopathology
- 김원배, "갑상선결절 및 암 진료 권고안", Endocrinology and Metabolism, 22(3), pp.157~187 (2007), 대한내분비학회
- 이가희, "2016년 대한갑상선학회 갑상선결절 및 암 진료 권고안 개정안", International Journal of Thyroidology, 9(2), pp.59~126 (2016), 대한갑상선학회
- 오은지, "Current Cytology Practices in Korea: A Nationwide Survey by the Korean Society for Cytopathology", Journal of Pathology and Translational Medicine, 51(6), pp.579~587 (2017), 대한병리학회[DOI]
- Cibas ES, "The Bethesda System For Reporting Thyroid Cytopathology", Am J Clin Pathol, 132, pp.658~665 (2009)
- "Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules", Diagn Cytopathol, 15, pp.84~89 (1996)
- Bongiovanni M, "The Bethesda System for Reporting Thyroid Cytopathology: a meta-analysis", Acta Cytol, 56, pp.333~339 (2012)
- Jung YY, "Significance of subcategory atypia of undetermined significance", follicular lesion of undetermined significance showing both cytologic and architectural atypia in thyroid aspiration cytology, 2015, pp.59, 370~376
- Kwon KH, "A study of usefulness of fine needle aspiration cytology of the thyroid lesions", Korean J Cytopathol, 7, pp.111~121 (1996)
- Park KM, "Diagnostic accuracy of fine needle aspiration cytology in thyroid lesions: analysis of histologically confirmed 153 cases", Korean J Cytopathol, 7, pp.122~133 (1996)
- 박지혜, "Incidence and Malignancy Rates of Diagnoses in the Bethesda System for Reporting Thyroid Aspiration Cytology: An Institutional Experience", Journal of Pathology and Translational Medicine, 48(2), pp.133~139 (2014), 대한병리학회[DOI]
- Lee YB, "Current status and diagnostic values of the Bethesda system for reporting thyroid cytopathology in a papillary thyroid carcinoma-prevalent area", Head Neck, 39, pp.269~274 (2017)
- 정찬권, "갑상샘 세침흡인세포검사 판독에 있어 베데스다 시스템의 적용", Journal of Pathology and Translational Medicine, 44(5), pp.521~527 (2010), 대한병리학회
- The Korean Society of Pathologist, "The History of the Korean Society of Pathologists 2006~2015", pp.20~21 (2015), The Korean Society of Pathologist
- Jung CK, "Split sample comparison of a liquid-based method and conventional smears in thyroid fine needle aspiration", Acta Cytol, 52, pp.313~319 (2008)
- Kim ES, "Absence of galectin-3 immunostaining in fine-needle aspiration cytology specimens from papillary thyroid carcinoma is associated with favorable pathological indices", Thyroid, 22, pp.1244~1250 (2012)
- Gweon HM, "Can galectin-3 be a useful marker for conventional papillary thyroid microcarcinoma", Diagn Cytopathol, 44, pp.103~107 (2016)
- Koo JS, "Cytologic characteristics and betacatenin immunocytochemistry on smear slide of cribriform-morular variant of papillary thyroid carcinoma", Acta Cytol, 55, pp.13~18 (2011)
- Jung YY, "Application of chemokine CXC motif ligand 12 as a novel diagnostic marker in preoperative fine-needle aspiration biopsy for papillary thyroid carcinoma", Acta Cytol, 57, pp.447~454 (2013)
- Lee SR, "VE1 antibody is not highly specific for the BRAF V600E mutation in thyroid cytology categories with the exception of malignant cases", Am J Clin Pathol, 143, pp.437~444 (2015)
- 김장희, "Evaluation of the VE1 Antibody in Thyroid Cytology Using Ex Vivo Papillary Thyroid Carcinoma Specimens", Journal of Pathology and Translational Medicine, 50(1), pp.58~66 (2016), 대한병리학회[DOI]
- Kwak JY, "Dual priming oligonucleotidebased multiplex PCR analysis for detection of BRAFV600E mutation in FNAB samples of thyroid nodules in BRAFV600E mutationprevalent area", Head Neck, 32, pp.490~498 (2010)
- So YK, "Preoperative BRAF mutation has different predictive values for lymph node metastasis according to tumor size", Otolaryngol Head Neck Surg, 145, pp.422~427 (2011)
- Lee SE, "Molecular profiling of papillary thyroid carcinoma in Korea with a high prevalence of BRAFV600E mutation", Thyroid, 27, pp.802~810 (2017)
- Kim Y, "Stability of DNA, RNA, cytomorphology, and immunoantigenicity in residual ThinPrep specimens", APMIS, 121, pp.1064~1072 (2013)
- 정찬권, "Pathology Reporting of Thyroid Core Needle Biopsy: A Proposal of the Korean Endocrine Pathology Thyroid Core Needle Biopsy Study Group", Journal of Pathology and Translational Medicine, 49(4), pp.288~299 (2015), 대한병리학회[DOI]